<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE344nnn/GSE344886/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE344886</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>RNA-seq analysis of bevacizumab-treated human glioblastoma cell line samples</name><description>This study characterizes transcriptomic changes associated with bevacizumab treatment in a human glioblastoma cell-line model. RNA sequencing was performed on bevacizumab-treated and untreated control cell samples cultured on a chip. Because the original FASTQ files are corrupted/currently unavailable, this GEO submission includes metadata and processed RNA-seq data files only, as advised by the GEO team under NCBI tracking system #25983490.</description><dates><publication>2026/08/29</publication></dates><accession>GSE344886</accession><cross_references><GSM>GSM9986995</GSM><GSM>GSM9986996</GSM><GSM>GSM9986993</GSM><GSM>GSM9986994</GSM><GSM>GSM9986991</GSM><GSM>GSM9986992</GSM><GPL>24676</GPL><GSE>344886</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>